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Introduction
Bronchoplastic procedures for lung cancer have the advantage
of preserving maximum lung parenchyma, thus offering
a potentially curative therapy for patients who would not
survive pneumonectomy due to poor pulmonary reserve.
In addition, the technique has been used in patients without
compromised pulmonary reserve, to improve postopera-
tive quality of life. It has also been reported to provide equiva-
lent or even better outcomes compared to radical lung resec-
tion.1–3 Thus, bronchoplasties are used increasingly to treat
bronchogenic carcinoma. However, limited information is
available regarding pulmonary arterioplastic and combined
Bronchoplastic and Pulmonary Arterioplastic Procedures
in the Treatment of Bronchogenic Carcinoma
broncho-angioplastic procedures.4,5 This retrospective study
analysed our 20-year experience with bronchoplastic, angio-
plastic and combined broncho-angioplastic operations in
the treatment of bronchogenic carcinoma, especially opera-
tive technique, indications and long-term results.
Patients and methods
Patients
A total of 65 bronchoplasties, four angioplasties, and three
combined broncho-angioplasties were performed for bron-
chogenic carcinoma in our institution between January 1981
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the carina were not included in this group. There were 68 men
and four women ranging in age from 20 to 66 years (mean age,
54.3 years).
In the same period, a total of 1,590 patients with broncho-
genic carcinoma underwent various lung resections in our
department. The 72 bronchoplastic and angioplastic proce-
dures comprised 4.5% of all operations for lung cancer. During
the first 10-year period from January 1981 to December 1990,
21 bronchoplastic and angioplastic procedures were performed
for bronchogenic carcinoma. In contrast, 51 patients under-
went the operation in the second 10-year period from January
1991 to December 2000. Bronchoplastic and angioplastic
procedures have been increasingly used in our department
through the past two decades.
Preoperative examination
All patients were preoperatively evaluated with bronchoscopy
and pulmonary function tests to determine the resectability
and predict postoperative lung function. If the tumour was
located at the lobe orifice or invaded the adjacent main
bronchus, it was considered anatomically suitable for a
bronchoplastic procedure. Predicted postoperative forced ex-
piratory volume in the first second (PppFEV1) was calculated
according to the following formula suggested by Juhl and
Frost:6 PppFEV1 = preoperative FEV1 × (1 – 0.0526S), where S
is the number of segments resected.
From 1986 onwards, patients were also evaluated with
computed tomography (CT) of the chest to identify any tu-
mour infiltration outside the bronchial lumen that could not
be detected by bronchoscopy.
Operative technique
Thoracotomy was performed through a posterolateral inci-
sion in the lateral position. Contralateral pulmonary ventila-
tion was achieved through either a double-lumen endotra-
cheal tube or a single-lumen tube with selective intubation of
the contralateral mainstem bronchus.
The operative procedure for bronchoplasty was identical
to that for standard lobectomy until the bronchus was isolated.
When the major lobe orifice was infiltrated by tumour, wedge
or sleeve bronchoplasty was performed. If the main bronchial
wall adjacent or, especially, opposite to the lobe orifice was
affected, sleeve bronchoplasty was mandatory. The bronchus
was divided and resected at a distance of not less than 1.0 cm
from the tumour in order to obtain a cancer-free margin.
Bronchial anastomosis was performed with a single row of
interrupted sutures. Non-absorbable suture material (silk or
nylon) was used in most patients, and absorbable suture
material (poliglactin 910) was used in only a few patients.
After completion of the bronchial anastomosis, it was
checked for air leaks by inflating the lung after filling the
thorax with saline solution. A well-vascularized pleural flap or
pedicled fat pad from the cardiophrenic angle was used to
cover the anastomotic site in order to prevent bronchial fistula
and erosion of the bronchial suture line into the pulmonary
artery.
The anastomosis of the pulmonary artery was performed
with interrupted non-absorbable sutures (polyester or silk).
Before anastomosis, 3,000 to 5,000 U of heparin was used at
the anastomotic site, but no heparin was used systemically.
The anastomotic site was also separated from the bronchial
suture line by a pedicled pleural flap or fat pad.
Statistical analyses
Postoperative survival rates were calculated by Kaplan-Meier
analysis, and statistical significance was assessed using the log
rank test. Differences were considered statistically significant
when p was less than 0.05.
Results
Indication for bronchoplasty and angioplasty
A total of 68 bronchoplastic procedures were performed. Of
these, 63 patients were anatomically suitable for the procedure,
as shown by preoperative bronchoscopy. Endobronchial tu-
mour was identified at the lobe orifice in 51 patients, in the
lobe bronchus with invasion of the adjacent main bronchial
wall in 11, and in the left mainstem bronchus in one. For the
remaining five patients, the decision for bronchoplasty was
made intraoperatively, due to metastatic lymph node adhe-
sion to the origin of the lobe bronchus in three patients and
extension of tumour onto the wall of the bronchus in two.
Seven angioplastic procedures were performed; the pul-
monary artery was involved through metastatic node adhe-
sion in five patients and direct tumour extension in two. All
angioplastic procedures were decided intraoperatively.
In all patients, PppFEV1 was not less than 1.0 L. However,
if pneumonectomy had been performed, PppFEV1 would have
been less than 1.0 L in 11 patients. Standard pneumonectomy
was contraindicated in these patients.
Type of procedures
Forty-five patients underwent sleeve bronchoplasty. Right
upper sleeve lobectomy was performed in 30 patients, includ-
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ing one with simultaneous middle lobectomy. Ten patients
underwent sleeve lobectomy of the left upper lobe, two of the
right upper and middle lobes, one of the right middle lobe and
one of the left lower lobe. One patient underwent sleeve resec-
tion of the left mainstem bronchus without removal of the
lung parenchyma.
Twenty patients underwent wedge resection of the main
bronchus. Fourteen patients underwent right upper lobec-
tomy with wedge resection of the main bronchus, including
two cases of concomitant middle lobectomy. Wedge resection
of the main bronchus was associated with left upper lobec-
tomy in two patients, left superior segmentectomy in two,
right middle lobectomy in one and left lower lobectomy in one.
Four patients underwent an angioplastic procedure with
standard lobectomy. Wedge resection of the pulmonary artery
with conventional left upper lobectomy was performed in two
patients, and with right upper lobectomy in one. The remain-
ing patient underwent sleeve resection of the pulmonary ar-
tery with standard left upper lobectomy.
Three patients underwent combined broncho-angioplasty
including sleeve right upper lobectomy with sleeve resection of
the pulmonary artery (n = 1), wedge left upper lobectomy with
wedge resection of the pulmonary artery (1), and wedge right
upper lobectomy with wedge resection of the pulmonary ar-
tery (1).
Thus, a total of 46 sleeve bronchoplastic, 22 wedge bron-
choplastic and seven pulmonary arterioplastic procedures were
performed in the 72 patients.
Pathology and classification
Histopathological diagnosis was squamous cell carcinoma in
58 patients, adenocarcinoma in four, small cell undifferenti-
ated carcinoma in four, mucoepidermoid carcinoma in three,
and adenosquamous carcinoma, carcinoid and malignant his-
tiocytoma in one each. According to the pTNM classification
proposed by the International Union Against Cancer,7 31 pa-
tients had stage I disease, 29 had stage II and 12 had stage III
disease. Postoperative pathological examination showed that
bronchial stump carcinoma was present in five patients (6.9%).
Postoperative mortality and morbidity
There were no intraoperative deaths. One patient died of
bilateral pneumonitis 10 days after surgery (postoperative
mortality rate, 1.4%). Four patients (5.6%) developed postop-
erative complications; atelectasis occurred in two patients
(2.8%), and empyema and bronchial fistula in one each (1.4%).
All patients with complications recovered through appropri-
ate postoperative treatment and care. No bronchial stenosis
developed after bronchoplasty, and the postoperative course
was uneventful in all seven patients who underwent arterial
reconstruction.
Long-term survival
Overall, the survival rate for the entire group was 86.0%, 47.0%
and 29.8% at 1, 3 and 5 years, respectively (Figure 1). Three-year
survival rates for patients with stage I, II and III disease were
69.4%, 32.3% and 25.0%, respectively. There was no 5-year
survival in patients with stage III disease, whereas 5-year sur-
vival rates in patients with stage I and II disease were 48.6% and
10.8%, respectively (Figure 2). There was a significant differ-
ence in survival between stage I and II disease (p = 0.0001) and
between stage I and III disease (p < 0.0001), but not between
stage II and III disease (p = 0.0779). In the seven patients who
had undergone pulmonary artery reconstruction, five died
within 2 postoperative years, and the remaining two were alive
at 1 year and 4 months, respectively.
Discussion
A bronchoplastic procedure is an optimal choice for patients
with lung cancer who cannot survive pneumonectomy due to
compromised pulmonary reserve. Luketich and Ginsberg re-
ported that patients who had a PppFEV1 of less than 1.0 L were
less likely to tolerate pneumonectomy than patients with
better predicted lung function.8 Preservation of lung tissue in
these patients is of paramount importance; thus, sleeve or
wedge lobectomy is the ideal option. In the present study, this
procedure provided an opportunity for tumour resection in
patients with compromised pulmonary function. Eleven
patients were considered unable to tolerate pneumonectomy
due to a PppFEV1 of less than 1 L. However, they tolerated the
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bronchoplastic procedure well. Suitable anatomic location of
the tumour was the major indication for the procedure in the
present study. A sleeve or wedge resection of the bronchus was
indicated when the tumour involved the lobe orifice or the
adjacent main bronchus, so that a standard lobectomy would
inevitably leave a positive bronchial resection margin. Sixty-
one patients who had normal pulmonary reserve underwent
bronchoplastic or angioplastic procedures. Thus, an anatomi-
cally suitable tumour location and reduced pulmonary reserve
were the indications for bronchoplastic procedure in the
present study. In our experience, combined use of broncho-
scopy and CT scan is helpful for designing bronchoplastic
procedures.
Intraoperative frozen-section analysis of the resected bron-
chial margin must be emphasized in all cases because postop-
erative pathological examination showed that bronchial stump
carcinoma existed in five patients (6.9%) in the present study.
Results from other series revealed that a positive bronchial
margin could be avoided by intraoperative frozen-section
examination.1,8–10 Bronchial stump carcinoma is definitely
the cause of local tumour recurrence, and may be the reason
why stage II and stage III patients’ survival was poorer than
expected in the present study.
Atelectasis is a common complication occurring in the
early period following bronchoplasty. Maggi and associates
reported that the incidence of postoperative atelectasis was
10.9% in 1985,1 whereas Gaissert and associates’ correspond-
ing figure was 5.6% in 1996.11 In our group, however, only 2.9%
(2/68) of patients who underwent bronchoplastic procedures
developed postoperative atelectasis, which was cured through
removal of endobronchial clots and secretions by repeated
bronchoscopy. Anastomotic fistula occurs occasionally after
bronchoplasty. Belli and associates reported one (5.3%) in 19
patients undergoing bronchoplastic procedures.9 In the present
study, however, only one anastomotic fistula (1.4%) was ob-
served. Anastomotic dehiscence and bronchovascular fistula
can be effectively prevented by wrapping the anastomotic site
with a pedicled pleural flap or fat pad. Bronchial stenosis is one
of the most common complications occurring in the late
period after bronchoplasty.1,9,10 Thrombosis occasionally oc-
curs in the pulmonary artery after angioplasty.1,9 However,
these late complications were not seen in the present study. In
our experience, bronchial stenosis can be prevented by using
small doses of steroids (fludrocortisone 5 mg/day for 10 days)
in the early postoperative period. In the process of performing
angioplastic procedures, the use of heparin at the anastomotic
site may prevent thrombosis in the pulmonary artery.
In recent years, sleeve lobectomy has been reported to be
associated with a lower incidence of postoperative morbidity
and mortality and similar long-term survival compared with
standard pneumonectomy. Yoshino and colleagues demon-
strated that the incidence of postoperative complications was
13.7% with sleeve lobectomy and 24.1% with pneumonec-
tomy (p > 0.05); the 3-year survival was 67.5% with sleeve
lobectomy and 58.5% with pneumonectomy (p > 0.05).3
Gaissert et al reported that the hospital mortality following
sleeve lobectomy was 4% compared with 9% following pneu-
monectomy (p < 0.05), whereas the 5-year survival rates for the
two groups were 42% and 44%, respectively (p > 0.05).11 In our
series, the morbidity and mortality were 5.6% and 1.4%,
respectively, and overall 5-year survival rate was 29.8%.
Du and associates summarized the long-term survival of
259 patients who underwent various lung resections for
lung cancer in our department between 1968 and 1979.12 The
5-year survival rates for conventional lobectomy and pneu-
monectomy were 23.8% and 13.3%, respectively. Thus,
bronchoplastic procedures are safe and have acceptable short-
term and long-term results.
In our experience, resection and reconstruction of the
pulmonary artery is not a very difficult operation. However,
disappointing long-term results limit its use. For this rea-
son, we suggest that angioplastic and combined broncho-
angioplastic procedures be used only in patients who cannot
survive pneumonectomy because of compromised cardio-
pulmonary reserve.
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